I agree that this site is using cookies. You can find further informations here.
X
Rowntree, J. K.
382  results:
Search for persons X
?
1

Results from UKALL60+, a phase 2 study in older patients wi..:

Patel, Bela ; Kirkwood, Amy A. ; Rowntree, Clare J....
HemaSphere.  8 (2024)  6 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
2

The environmental dependence of the stellar mass–gas metall..:

Rowntree, Aaron R ; Singh, Ankit ; Vincenzo, Fiorenzo...
Monthly Notices of the Royal Astronomical Society.  531 (2024)  4 - p. 3858-3875 , 2024
Link: https://doi.org/10.1093/..
 
?
3

Immunogenicity and protective efficacy of a co-formulated t..:

Handabile, C ; Ohno, M ; Sekiya, T...
issn:2045-2322.  , 2024
Link: http://hdl.handle.net/11..
 
?
4

Table S2 from Site-Specific Dolasynthen Antibody–Drug Conju..:

Susan M. Clardy ; Alex Uttard ; Bingfan Du...
doi:10.1158/1535-7163.24935461.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
5

Supplemental Data File 1 from Site-Specific Dolasynthen Ant..:

Susan M. Clardy ; Alex Uttard ; Bingfan Du...
doi:10.1158/1535-7163.24935467.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
6

Figure S2 from Site-Specific Dolasynthen Antibody–Drug Conj..:

Susan M. Clardy ; Alex Uttard ; Bingfan Du...
doi:10.1158/1535-7163.24935479.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
7

Increasing HbA1c is associated with reduced CD8 + T cell fu..:

Hulme, KD ; Tong, ZWM ; Rowntree, LC...
issn:1420-682X.  , 2024
Link: http://hdl.handle.net/11..
 
?
8

Figure S3 from Site-Specific Dolasynthen Antibody–Drug Conj..:

Susan M. Clardy ; Alex Uttard ; Bingfan Du...
doi:10.1158/1535-7163.24935476.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
9

Table S1 from Site-Specific Dolasynthen Antibody–Drug Conju..:

Susan M. Clardy ; Alex Uttard ; Bingfan Du...
doi:10.1158/1535-7163.24935464.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
10

Figure S1 from Site-Specific Dolasynthen Antibody–Drug Conj..:

Susan M. Clardy ; Alex Uttard ; Bingfan Du...
doi:10.1158/1535-7163.24935482.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
11

Table S3 from Site-Specific Dolasynthen Antibody–Drug Conju..:

Susan M. Clardy ; Alex Uttard ; Bingfan Du...
doi:10.1158/1535-7163.24935458.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
12

Table S4 from Site-Specific Dolasynthen Antibody–Drug Conju..:

Susan M. Clardy ; Alex Uttard ; Bingfan Du...
doi:10.1158/1535-7163.24935455.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
13

Figure S4 from Site-Specific Dolasynthen Antibody–Drug Conj..:

Susan M. Clardy ; Alex Uttard ; Bingfan Du...
doi:10.1158/1535-7163.24935473.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
14

Results from UKALL60+,:a phase 2 study in older patients wi..:

Patel, Bela ; Kirkwood, Amy A ; Rowntree, Clare J...
https://pure.eur.nl/en/publications/d6be1948-c353-4db4-96a6-f4f1f7130fea.  , 2024
Link: https://pure.eur.nl/en/p..
 
?
15

Broad spectrum SARS‐CoV‐2‐specific immunity in hospitalized..:

Zhang, Wuji ; Clemens, E Bridie ; Kedzierski, Lukasz...
Immunology & Cell Biology.  101 (2023)  10 - p. 964-974 , 2023
Link: https://doi.org/10.1111/..
 
1-15